Robert L. Roy, PE, senior consultant; Jason S. Collins, RA, NCARB, senior process architect; and Louis Isernia, project manager, have joined Integrated Project Services’ Advanced Aseptic Technologies Group. The group provides engineering, compliance, operational consulting and construction services for technically complex aseptic projects. The team is led by Sterling Kline, RA.
“We are pleased that Rob, Jason and Lou have joined IPS,” said John Gilroy, PE, senior vice president and principal. “Each brings invaluable professional experience in all phases of advanced aseptic processing and containment technology including manufacturing operations, engineering, project management and delivery, quality and qualification.”
Mr. Roy has more than 20 years of industry experience with specialized expertise in barrier isolation technology, single-use technology, potent material handling and containment, cleaning validation and Clean-In-Place (CIP) and Sterilization-In-Place (SIP) systems. Mr. Roy has held positions with Bosch Packaging, Inc., Bristol-Myers Squibb, and Isogen, LLC, before joining IPS.
Mr. Collins is a process architect developing concepts of pharmaceutical facilities for various clients around the world. He uses 3-D modeling and unique visualization techniques to take clients through the conceptual layout phase and for the development of unit operations. Mr. Collins is also experienced in detail architectural design and construction related services. Most recently, he was with Jacobs Engineering, Inc. as a Process/Project Architect on multiple, technically complex projects which included programming, conceptual design, basis of design development, detail design and construction administration.
Mr. Isernia brings 25 years of experience in the design, construction and commissioning and qualification of aseptic, vaccine and biotech manufacturing operations. As Pfizer PGE Engineering site lead, Mr. Isernia led all site engineering activities in support of capital projects, renovations, new construction and energy conservation management programs. Previously, he managed design teams of engineering consultants and colleagues on design, construction and commissioning of biopharmaceutical facilities at Wyeth.
Mr. Kline is a subject matter expert in aseptic facility design and sterile isolator technology. He has more than 35 years of experience and has completed aseptic projects ranging from clinical manufacturing pilot plants for aseptic and potent compounds, to manufacturing facilities for sterile products using vials, syringes and devices incorporating both traditional and isolation technology. He has served in senior management roles at engineering and construction service firms. Mr. Kline has also served as a director of engineering for global pharmaceutical manufacturers such as Bristol-Myers Squibb and DuPont Pharma.